PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue

Journal of Immunology

Volumn 181, Issue 8, 2008, Pages 5313-5322

  Koehn, Brent H ^a   Ford, Mandy L ^a   Ferrer, Ivana R ^a   Borom, Keshawna ^a   Gangappa, Shivaprakash ^a   Kirk, Allan D ^a   Larsen, Christian P ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD28 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; PROGRAMMED CELL DEATH 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; PD 1 ANTIGEN, MOUSE; PD-1 ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IN VIVO STUDY; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN TRANSPLANTATION; T CELL DEPLETION; T LYMPHOCYTE; THYMUS; UPREGULATION; ALLOTRANSPLANTATION; ANIMAL; IMMUNOLOGY; MOUSE MUTANT; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; GRAFT SURVIVAL; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SKIN TRANSPLANTATION; THYMUS GLAND; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

EID: 54049098297     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.8.5313     Document Type: Article

References (52)

1. Jenkins, M. K. 1994. The ups and downs of T cell costimulation. Immunity 1: 443-446.
2. Turka, L. A., P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R. Wei, M. L. Gibson, X. Zheng, S. Myrdal, D. Gordon, et al. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89: 11102-11105.
3. Pearson, T. C., D. Z. Alexander, M. Corbascio, R. Hendrix, S. C. Ritchie, P. S. Linsley, D. Faherty, and C. P. Larsen. 1997. Analysis of the B7 costimulatory pathway in allograft rejection. Transplantation 63: 1463-1469. (Pubitemid 27237452)
4. Pearson, T. C., D. Z. Alexander, K. J. Winn, P. S. Linsley, R. P. Lowry, and C. P. Larsen. 1994. Transplantation tolerance induced by CTLA4-Ig. Transplantation 57: 1701-1706.
5. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L. A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181: 1869-1874.
6. Lenschow, D., Y. Zeng, J. Thistlethwaite, A. Montag, W. Brady, M. Gibson, P. Linsley, and J. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257: 789-792.
7. Adams, A. B., N. Shirasugi, T. R. Jones, M. M. Durham, E. A. Strobert, S. Cowan, P. Rees, R. Hendrix, K. Price, N. S. Kenyon, et al. 2005. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J. Immunol. 174: 542-550.
8. Haanstra, K. G., J. Ringers, E. A. Sick, S. Ramdien-Murli, E. M. Kuhn, L. Boon, and M. Jonker. 2003. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates. Transplantation 75: 637-643.
9. Haanstra, K. G., E. A. Sick, J. Ringers, J. A. Wubben, E. M. Kuhn, L. Boon, and M. Jonker. 2005. Costimulation blockade followed by a 12-week period of cyclosporine A facilitates prolonged drug-free survival of rhesus monkey kidney allografts. Transplantation 79: 1623-1626.
10. Kirk, A. D., L. C. Burkly, D. S. Batty, R. E. Baumgartner, J. D. Berning, K. Buchanan, J. H. Fechner, Jr., R. L. Germond, R. L. Kampen, N. B. Patterson, et al. 1999. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. 5: 686-693.
11. Kirk, A. D., D. M. Harlan, N. N. Armstrong, T. A. Davis, Y. Dong, G. S. Gray, X. Hong, D. Thomas, J. H. Fechner, and S. J. Knechtle. 1997. CTLA4Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94: 8789-8794.
12. Sharpe, A. H., E. J. Wherry, R. Ahmed, and G. J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8: 239-245.
13. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
14. Freeman, G. J., E. J. Wherry, R. Ahmed, and A. H. Sharpe. 2006. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203: 2223-2227.
15. + T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J. Virol. 80: 3532-3540.
16. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
17. + T cell survival in HIV infection. J. Exp. Med. 203: 2281-2292.
18. + T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
19. Urbani, S., B. Amadei, D. Tola, M. Massari, S. Schivazappa, G. Missale, and C. Ferrari. 2006. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 80: 11398-11403. (Pubitemid 44706581)
20. Fife, B. T., I. Guleria, M. Gubbels Bupp, T. N. Eagar, Q. Tang, H. Bour-Jordan, H. Yagita, M. Azuma, M. H. Sayegh, and J. A. Bluestone. 2006. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 203: 2737-2747.
21. Keir, M. E., S. C. Liang, I. Guleria, Y. E. Latchman, A. Qipo, L. A. Albacker, M. Koulmanda, G. J. Freeman, M. H. Sayegh, and A. H. Sharpe. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203: 883-895.
22. + T cell tolerance to tissue antigens. J. Immunol. 177: 8291-8295.
23. Ansari, M. J., A. D. Salama, T. Chitnis, R. N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S. J. Khoury, et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198: 63-69.
24. Salama, A. D., T. Chitnis, J. Imitola, M. J. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198: 71-78.
25. Blazar, B. R., B. M. Carreno, A. Panoskaltsis-Mortari, L. Carter, Y. Iwai, H. Yagita, H. Nishimura, and P. A. Taylor. 2003. Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-γ- dependent mechanism. J. Immunol. 171: 1272-1277.
26. Ito, T., T. Ueno, M. R. Clarkson, X. Yuan, M. M. Jurewicz, H. Yagita, M. Azuma, A. H. Sharpe, H. Auchincloss, Jr., M. H. Sayegh, and N. Najafian. 2005. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J. Immunol. 174: 6648-6656. (Pubitemid 40705625)
27. Sandner, S. E., M. R. Clarkson, A. D. Salama, A. Sanchez-Fueyo, C. Domenig, A. Habicht, N. Najafian, H. Yagita, M. Azuma, L. A. Turka, and M. H. Sayegh. 2005. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J. Immunol. 174: 3408-3415.
28. Tao, R., L. Wang, R. Han, T. Wang, Q. Ye, T. Honjo, T. L. Murphy, K. M. Murphy, and W. W. Hancock. 2005. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J. Immunol. 175: 5774-5782. (Pubitemid 41508061)
29. Gao, W., G. Demirci, T. B. Strom, and X. C. Li. 2003. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation 76: 994-999.
30. Ozkaynak, E., L. Wang, A. Goodearl, K. McDonald, S. Qin, T. O'Keefe, T. Duong, T. Smith, J. C. Gutierrez-Ramos, J. B. Rottman, et al. 2002. Programmed death-1 targeting can promote allograft survival. J. Immunol. 169: 6546-6553. (Pubitemid 36903507)
31. Watson, M. P., A. J. George, and D. F. Larkin. 2006. Differential effects of costimulatory pathway modulation on corneal allograft survival. Invest. Ophthalmol. Visual Sci. 47: 3417-3422.
32. Tanaka, K., M. J. Albin, X. Yuan, K. Yamaura, A. Habicht, T. Murayama, M. Grimm, A. M. Waaga, T. Ueno, R. F. Padera, et al. 2007. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J. Immunol. 179: 5204-5210.
33. Ford, M. L., B. H. Koehn, M. E. Wagener, W. Jiang, S. Gangappa, T. C. Pearson, and C. P. Larsen. 2007. Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J. Exp. Med. 204: 299-309.
34. + T cell-mediated CD28/CD154-independent rejection. J. Immunol. 180: 7203-7211.
35. Ehst, B. D., E. Ingulli, and M. K. Jenkins. 2003. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am. J. Transplant. 3: 1355-1362.
36. Xu, H., B. G. Exner, P. M. Chilton, C. Schanie, and S. T. Ildstad. 2004. CD45 congenic bone marrow transplantation: evidence for T cell-mediated immunity. Stem Cells 22: 1039-1048. (Pubitemid 39507090)
37. Agata, Y., A. Kawasaki, H. Nishimura, Y. Ishida, T. Tsubata, H. Yagita, and T. Honjo. 1996. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8: 765-772. (Pubitemid 26148299)
38. Adams, A. B., M. M. Durham, L. Kean, N. Shirasugi, J. Ha, M. A. Williams, P. A. Rees, M. C. Cheung, S. Mittelstaedt, A. W. Bingaman, et al. 2001. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J. Immunol. 167: 1103-1111.
39. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434-438.
40. Suchin, E. J., P. B. Langmuir, E. Palmer, M. H. Sayegh, A. D. Wells, and L. A. Turka. 2001. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166: 973-981.
41. He, C., S. Schenk, Q. Zhang, A. Valujskikh, J. Bayer, R. L. Fairchild, and P. S. Heeger. 2004. Effects of T cell frequency and graft size on transplant outcome in mice. J. Immunol. 172: 240-247. (Pubitemid 38020477)
42. Wekerle, T., M. H. Sayegh, J. Hill, Y. Zhao, A. Chandraker, K. G. Swenson, G. Zhao, and M. Sykes. 1998. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187: 2037-2044. (Pubitemid 28285573)
43. Iwakoshi, N. N., T. G. Markees, N. Turgeon, T. Thornley, A. Cuthbert, J. Leif, N. E. Phillips, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 2001. Skin allograft maintenance in a new synchimeric model system of tolerance. J. Immunol. 167: 6623-6630.
44. + T cells, precluding a role for sustained regulation. Eur. J. Immunol. 35: 2679-2690.
45. Ito, H., J. Kurtz, J. Shaffer, and M. Sykes. 2001. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway. J. Immunol. 166: 2970-2981. (Pubitemid 33117292)
46. + T cell activation and cytolysis. Eur. J. Immunol. 33: 3117-3126.
47. Kalled, S. L., A. H. Cutler, and J. L. Ferrant. 2001. Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosis. Lupus 10: 9-22.
48. Pearson, T., T. G. Markees, L. S. Wicker, D. V. Serreze, L. B. Peterson, J. P. Mordes, A. A. Rossini, and D. L. Greiner. 2003. NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction. Diabetes 52: 321-326. (Pubitemid 36173185)
49. Bolling, S. F., H. Lin, and L. A. Turka. 1996. The time course of CTLAIg effect on cardiac allograft rejection. J. Surg. Res. 63: 320-323.
50. Linsley, P. S., P. M. Wallace, J. Johnson, M. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257: 792-795.
51. + T reg cells. J. Exp. Med. 203: 1701-1711.
52. + regulatory T cell induced by ICOS-B7h blockade in vivo. J. Immunol. 179: 786-796.